13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 6 managers

Reported value

$7.47M

Holders

6

+0 new · −0 exited

Holders’ est. mark

−$408.3K

Price effect on 3 books still in the name

Largest holder

$3.28M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC100K$3.28M−$341KCut−$1.17M
NORGES BANK71K$2.32MHeld
OP Asset Management Ltd26.9K$879.9KHeld
Henshaw Capital LLC21.1K$689.5K−$67KCut−$20.7K
FIRST NATIONAL BANK OF OMAHA9.19K$301KHeld
DANSKE BANK A/S100$3.27K−$341Cut−$341

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.